Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration

scientific article

Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JCONREL.2004.03.003
P698PubMed publication ID15212874

P2093author name stringQiang Zhang
Tao Zhang
Xue-Qing Wang
Zhen Chen
T Nagai
Jun-Dong Dai
Gui-Min Xia
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
pharmacokineticsQ323936
cyclosporineQ367700
bioavailabilityQ461809
P304page(s)421-429
P577publication date2004-07-01
P1433published inJournal of Controlled ReleaseQ6295046
P1476titleBioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration
P478volume97

Reverse relations

cites work (P2860)
Q84318241A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate
Q39671883Development and validation of a HPLC method for the determination of cyclosporine a in new bioadhesive nanoparticles for oral administration
Q35071614Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
Q29307905Microemulsions for oral administration and their therapeutic applications
Q35154212Nano composite emulsion for sustained drug release and improved bioavailability
Q57343790Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
Q37324276Oral cyclosporine A--the current picture of its liposomal and other delivery systems.
Q27023585Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?
Q33644850Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles
Q97540743Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects
Q33906267Preparation of polymeric nanoparticles of cyclosporin A using infrared pulsed laser
Q27001699Recent advances in oral vaccine development: yeast-derived β-glucan particles
Q42199025Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design

Search more.